<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/DCAA18E5-BBD4-4EFC-AF59-B093758D2D13"><gtr:id>DCAA18E5-BBD4-4EFC-AF59-B093758D2D13</gtr:id><gtr:firstName>Aleksandar</gtr:firstName><gtr:surname>Jovanovic</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0400608"><gtr:id>1455EB32-D752-4088-8953-83CDC385BFDE</gtr:id><gtr:title>The involvement of M-LDH physically associated with sarcolemmal KATP channel subunits in cardioprotection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400608</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2008-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>196154</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>Cardioprotection afforded by AMPK</gtr:description><gtr:id>C846EDB4-EA09-4247-89FC-24961C1EA11A</gtr:id><gtr:impact>This collaboration has resulted in a publication (pubmed No 17044064)</gtr:impact><gtr:partnerContribution>The Partner has provided transgenic mice for our use and has contributed to data analysis and distribution.</gtr:partnerContribution><gtr:piContribution>We have designed and executed the study, and analysed and distributed the data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Protein Phosphorylation Unit</gtr:department><gtr:description>Cardioprotection afforded by PDK1</gtr:description><gtr:id>B004ECBC-9E22-48F3-AE69-8106DE5FA251</gtr:id><gtr:impact>Publication 17077284 has resulted from this collaboration.</gtr:impact><gtr:partnerContribution>The partners provided transgenic animals allowing us to perform this research.</gtr:partnerContribution><gtr:piContribution>We conducted a study using transgenic animals from our partner.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Life Sciences</gtr:department><gtr:description>Cardioprotection afforded by LKB</gtr:description><gtr:id>8DEA7595-6848-4F53-806F-1BF21D8ED574</gtr:id><gtr:impact>The collaboration has resulted in publication (pubmed No 16332922). In addition, it has resulted a Project Grant awarded by the British heart Foundation.</gtr:impact><gtr:partnerContribution>The partner has contributed to the study design, execution, data analysis and data distribution.</gtr:partnerContribution><gtr:piContribution>We have contributed to the execution of the study, data analysis and data distribution.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Protein Phosphorylation Unit</gtr:department><gtr:description>Regulation of blood pressure by WNK-activated SPAK kinase</gtr:description><gtr:id>58129335-C826-4049-A9A0-A70A2001CD34</gtr:id><gtr:impact>Publication 20091762 resulted from this collaboration.</gtr:impact><gtr:partnerContribution>We got transgenic mice to perform this research.</gtr:partnerContribution><gtr:piContribution>We have contributed to all aspects of this study including performing telemetry experiments on transgenic mice.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>University of Dundee website</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>45771AE5-7293-48AF-8230-16144313D4B5</gtr:id><gtr:impact>The results obtained from this study are on the University of Dundee website.

The results can be viewed by anybody with the internet access.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>AAFCE244-0709-45A5-9EF0-F1E6EB41E161</gtr:id><gtr:impact>This was a public lecture aimed on lay audience that come all over Scotland. Among others, results from this MRC study were also presented.

The lecture was received very well and rose a lot of interest.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ResearchGate</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F51D0663-54B9-494C-9E1B-CEA1D3BCA52C</gtr:id><gtr:impact>&amp;gt;6000 people viewed my publications and &amp;gt;1000 people downloaded my papers.

Increased dissemination of information stemming for AJ work.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.researchgate.net/profile/Aleksandar_Jovanovic6/info?ev=prf_info</gtr:url><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>170000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>IES SUR2B-mediated cardioprotection</gtr:description><gtr:end>2019-01-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>PG/15/28/31384</gtr:fundingRef><gtr:id>ECDD5255-1D0F-4411-A4C0-D4934AEFF18F</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>136679</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF funding (Overexpression of SUR2A as a strategy to counteract ageing-induced increase in myocardial susceptibility to ischaemia)</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>B392A0AF-E836-4722-A279-EBF71924C72A</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>95646</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Increased expression of SUR2A as a strategy to counteract ageing-induced decrease in cardiac output and physical endurance</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>01A9A89F-51EF-4D5C-8AF1-3002032CA5D8</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>154293</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF funding (Non-channel aspects of sarcolemmal KATP channels and cardioprotection)</gtr:description><gtr:end>2010-03-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>DD38C692-FD62-4936-A8E9-A3E37F26FF10</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citations in reviews published in clinical journals</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>AE8E5F7E-B764-4461-B2A9-1757F5AB1142</gtr:id><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>This is annexin-luciferase subcloned into adenoviral vector.</gtr:description><gtr:id>FD7FFDA0-A91D-42AE-870B-578DD45E50CD</gtr:id><gtr:impact>This can be used to specifically measure subsarcolemmal level of ATP.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Annexin-luciferase</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>These are mutant/truncated forms of M-LDH subcloned into adenoviral vectors.</gtr:description><gtr:id>D31ACDB4-ECC0-40D8-938A-2A84E6E54ACD</gtr:id><gtr:impact>These mutants are useful tool when assesment of any physiological role of M-LDH is required.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Mutants of M-LDH</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/41D96FB4-9EE8-406C-B24E-6BEABADB583B"><gtr:id>41D96FB4-9EE8-406C-B24E-6BEABADB583B</gtr:id><gtr:title>M-LDH physically associated with sarcolemmal K ATP channels mediates cytoprotection in heart embryonic H9C2 cells.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c81c20f5cd63004354a5d647e215f65e"><gtr:id>c81c20f5cd63004354a5d647e215f65e</gtr:id><gtr:otherNames>Jovanovic S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EC8687F0-27BE-433C-B613-8DB45BACE5D3"><gtr:id>EC8687F0-27BE-433C-B613-8DB45BACE5D3</gtr:id><gtr:title>AMP-activated protein kinase mediates preconditioning in cardiomyocytes by regulating activity and trafficking of sarcolemmal ATP-sensitive K(+) channels.</gtr:title><gtr:parentPublicationTitle>Journal of cellular physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f8ecba36f6b93a269a7af3dc1d0de0ef"><gtr:id>f8ecba36f6b93a269a7af3dc1d0de0ef</gtr:id><gtr:otherNames>Sukhodub A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9541</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4A6FD5F0-FD68-424D-B4C5-E0C263348BA8"><gtr:id>4A6FD5F0-FD68-424D-B4C5-E0C263348BA8</gtr:id><gtr:title>High glucose protects single beating adult cardiomyocytes against hypoxia.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c81c20f5cd63004354a5d647e215f65e"><gtr:id>c81c20f5cd63004354a5d647e215f65e</gtr:id><gtr:otherNames>Jovanovic S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6D026D4A-CC89-433D-848C-6167CB1146F1"><gtr:id>6D026D4A-CC89-433D-848C-6167CB1146F1</gtr:id><gtr:title>Ageing, gender and cardiac sarcolemmal K(ATP) channels.</gtr:title><gtr:parentPublicationTitle>The Journal of pharmacy and pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cc4cf1e7d99d9cd51c5e6c26710258c9"><gtr:id>cc4cf1e7d99d9cd51c5e6c26710258c9</gtr:id><gtr:otherNames>Jovanovic A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-3573</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E6161E30-E05C-4747-AFA3-80B6C3D40F7D"><gtr:id>E6161E30-E05C-4747-AFA3-80B6C3D40F7D</gtr:id><gtr:title>Infection with AV-SUR2A protects H9C2 cells against metabolic stress: a mechanism of SUR2A-mediated cytoprotection independent from the K(ATP) channel activity.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/aec43283d1ef92bff9f1c1c9ea8f8062"><gtr:id>aec43283d1ef92bff9f1c1c9ea8f8062</gtr:id><gtr:otherNames>Du Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/36363DBF-F5F7-4428-8116-C100A883AB6A"><gtr:id>36363DBF-F5F7-4428-8116-C100A883AB6A</gtr:id><gtr:title>Nicotinamide-rich diet protects the heart against ischaemia-reperfusion in mice: a crucial role for cardiac SUR2A.</gtr:title><gtr:parentPublicationTitle>Pharmacological research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f8ecba36f6b93a269a7af3dc1d0de0ef"><gtr:id>f8ecba36f6b93a269a7af3dc1d0de0ef</gtr:id><gtr:otherNames>Sukhodub A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1043-6618</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6BAB88A4-DF89-48FF-8D09-414C126DF478"><gtr:id>6BAB88A4-DF89-48FF-8D09-414C126DF478</gtr:id><gtr:title>Role of the WNK-activated SPAK kinase in regulating blood pressure.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8e8660ffcd43f0a0d94f9241c2e0dc91"><gtr:id>8e8660ffcd43f0a0d94f9241c2e0dc91</gtr:id><gtr:otherNames>Rafiqi FH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2871E348-E99E-4044-9DDD-643A51C40C23"><gtr:id>2871E348-E99E-4044-9DDD-643A51C40C23</gtr:id><gtr:title>3'Phosphoinositide-dependent kinase-1 is essential for ischemic preconditioning of the myocardium.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d7907342793d2ec9e88f76f89c919430"><gtr:id>d7907342793d2ec9e88f76f89c919430</gtr:id><gtr:otherNames>Budas GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EF6999B2-B423-4537-98E3-8F7D0BECC378"><gtr:id>EF6999B2-B423-4537-98E3-8F7D0BECC378</gtr:id><gtr:title>Mg2+ protects adult beating cardiomyocytes against ischaemia.</gtr:title><gtr:parentPublicationTitle>International journal of molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6d4a8353c9298605fc4cd6e5bcb1ab32"><gtr:id>6d4a8353c9298605fc4cd6e5bcb1ab32</gtr:id><gtr:otherNames>Faghihi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1107-3756</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B2DA40A8-F098-43F3-891B-C6B1FE80AC57"><gtr:id>B2DA40A8-F098-43F3-891B-C6B1FE80AC57</gtr:id><gtr:title>Overexpression of SUR2A generates a cardiac phenotype resistant to ischemia.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/aec43283d1ef92bff9f1c1c9ea8f8062"><gtr:id>aec43283d1ef92bff9f1c1c9ea8f8062</gtr:id><gtr:otherNames>Du Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B77C90A0-0A05-4F96-B540-A9E080E7FC5E"><gtr:id>B77C90A0-0A05-4F96-B540-A9E080E7FC5E</gtr:id><gtr:title>High glucose regulates the activity of cardiac sarcolemmal ATP-sensitive K+ channels via 1,3-bisphosphoglycerate: a novel link between cardiac membrane excitability and glucose metabolism.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c81c20f5cd63004354a5d647e215f65e"><gtr:id>c81c20f5cd63004354a5d647e215f65e</gtr:id><gtr:otherNames>Jovanovic S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/09EDB790-6580-4747-BD93-54B3ED1B2935"><gtr:id>09EDB790-6580-4747-BD93-54B3ED1B2935</gtr:id><gtr:title>A patient suffering from hypokalemic periodic paralysis is deficient in skeletal muscle ATP-sensitive K channels.</gtr:title><gtr:parentPublicationTitle>Clinical and translational science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c81c20f5cd63004354a5d647e215f65e"><gtr:id>c81c20f5cd63004354a5d647e215f65e</gtr:id><gtr:otherNames>Jovanovic S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1752-8054</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/01664427-A539-4029-8BCF-100BE0BBF842"><gtr:id>01664427-A539-4029-8BCF-100BE0BBF842</gtr:id><gtr:title>A dual mechanism of cytoprotection afforded by M-LDH in embryonic heart H9C2 cells.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c81c20f5cd63004354a5d647e215f65e"><gtr:id>c81c20f5cd63004354a5d647e215f65e</gtr:id><gtr:otherNames>Jovanovic S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/382E38B6-4B42-4E4C-870A-7DF1C79B22D0"><gtr:id>382E38B6-4B42-4E4C-870A-7DF1C79B22D0</gtr:id><gtr:title>An unexpected negative inotropic effect of prostaglandin F2alpha in the rat heart.</gtr:title><gtr:parentPublicationTitle>Prostaglandins &amp; other lipid mediators</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6699c74d89e6e5c59e0c6e8f4d4e54e8"><gtr:id>6699c74d89e6e5c59e0c6e8f4d4e54e8</gtr:id><gtr:otherNames>Jovanovic N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1098-8823</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8EDE8D70-6416-42CE-B463-4CAB9462CB10"><gtr:id>8EDE8D70-6416-42CE-B463-4CAB9462CB10</gtr:id><gtr:title>SURA2 targeting for cardioprotection?</gtr:title><gtr:parentPublicationTitle>Current opinion in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cc4cf1e7d99d9cd51c5e6c26710258c9"><gtr:id>cc4cf1e7d99d9cd51c5e6c26710258c9</gtr:id><gtr:otherNames>Jovanovic A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-4892</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1F6632D5-4089-48F3-8A84-2AA363F1CAB5"><gtr:id>1F6632D5-4089-48F3-8A84-2AA363F1CAB5</gtr:id><gtr:title>Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKalpha2 but not AMPKalpha1.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d3b82cf28b98a880d0dd4505fac4534f"><gtr:id>d3b82cf28b98a880d0dd4505fac4534f</gtr:id><gtr:otherNames>Sakamoto K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0193-1849</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400608</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>